| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,380 |
7,592 |
$536K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,501 |
1,419 |
$138K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,496 |
1,483 |
$113K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,357 |
1,347 |
$112K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,235 |
1,202 |
$92K |
| 92551 |
|
4,817 |
4,713 |
$48K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
632 |
557 |
$45K |
| 90677 |
|
418 |
394 |
$33K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
675 |
614 |
$26K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,873 |
1,812 |
$26K |
| 90686 |
|
1,941 |
1,890 |
$24K |
| 90651 |
|
344 |
338 |
$18K |
| 90621 |
|
409 |
406 |
$17K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,662 |
1,612 |
$15K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,515 |
3,348 |
$13K |
| 90734 |
|
347 |
342 |
$13K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
123 |
122 |
$10K |
| 99177 |
|
2,494 |
2,468 |
$10K |
| 96127 |
|
1,802 |
1,788 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
648 |
311 |
$9K |
| 90680 |
|
354 |
325 |
$8K |
| 90723 |
|
341 |
313 |
$7K |
| 90661 |
|
535 |
515 |
$6K |
| 99173 |
|
2,215 |
2,165 |
$5K |
| 90633 |
|
342 |
329 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
137 |
129 |
$5K |
| 90647 |
|
355 |
329 |
$5K |
| 90670 |
|
134 |
125 |
$5K |
| 87428 |
|
135 |
133 |
$4K |
| 85018 |
|
1,512 |
1,465 |
$3K |
| 90710 |
|
93 |
91 |
$3K |
| 90461 |
|
1,140 |
1,070 |
$3K |
| 87807 |
|
179 |
168 |
$2K |
| 97802 |
|
79 |
74 |
$2K |
| 90715 |
|
117 |
116 |
$2K |
| 90716 |
|
70 |
68 |
$2K |
| 90696 |
|
91 |
87 |
$1K |
| 85014 |
|
573 |
558 |
$1K |
| 83655 |
|
113 |
105 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
559 |
546 |
$1K |
| 99188 |
|
54 |
54 |
$1K |
| 90700 |
|
73 |
72 |
$860.72 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
99 |
89 |
$655.64 |
| 90707 |
|
42 |
42 |
$618.99 |
| 91318 |
|
14 |
12 |
$562.42 |
| 81002 |
|
163 |
157 |
$477.61 |
| 90480 |
|
21 |
19 |
$400.00 |
| 86580 |
|
15 |
14 |
$128.55 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
42 |
41 |
$11.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
99 |
89 |
$5.00 |